Latest filing published 14 Mar 2023 for Zymeworks Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Neil A. Klompas: trading record in brief
Neil A. Klompas (finance chief) discloses dealings in Zymeworks Inc. to SEC (Form 4). We count 27 filings; the first trade dates from 8 January 2019 and the latest from 10 March 2023.
Every open-market trade on record is a sale: 7 sales worth €2.4M. Outside the open market, there are 9 share grants and 11 option exercises. 2023 to date brings no purchases and 1 sale.
The record was last updated on 14 March 2023 with an open-market sale (€22k) in Zymeworks Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Neil A. Klompas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,500 shares0Common StockSEC:0000899243-23-008432:0
- 1,525 shares@ US$4.5123.6% of flowCommon SharesSEC:0000899243-22-025151:0
- 2,500 shares0Common SharesSEC:0000899243-22-010795:0
- 277 shares@ US$13.9419.4% of flowCommon SharesSEC:0000899243-22-001423:0
- 299 shares@ US$29.4942.4% of flowCommon SharesSEC:0000899243-21-027913:0
5 of 5 declarations
